Biomedical Research & Development Center

Biomedical Research & Development Center is advancing biomedical innovation through integrative medicine, synthetic biology, and cutting-edge therapies to address global health challenges. 

  • Integrative Medicine: Explore clinical treatment plans combining traditional Chinese and Western medicine for complex and critical illnesses. Gradually establish integrative diagnosis and treatment centers in Hong Kong to enhance the medical service capabilities and international competitiveness of the Greater Bay Area.
  • Synthetic Biology: Leverage Hong Kong's strengths in bioinformatics, genetic engineering, and automation technology, combined with the Greater Bay Area's well-established bio-research infrastructure. Aim to become a globally leading innovation center in synthetic biology and drive the upgrading of the biopharmaceutical industry.
  • Biomanufacturing: Focus on developing technologies for the biopharmaceutical industry, including new bioreactors, efficient cell culture and purification processes, and intelligent production management systems. Enable efficient, low-cost, and large-scale production of biologics, biomaterials, and diagnostic reagents, addressing global health and well-being.
  • Gene and Cell Therapy: Build on Hong Kong's strengths in genomics, cell biology, and clinical medicine, in collaboration with the clinical resources and medical institutions of the Greater Bay Area. Focus on cutting-edge technologies in gene and cell therapy, such as gene editing therapy, immunotherapy, and stem cell therapy.
  • Innovative Drug Development: Emphasize the development of small molecule drugs, antibody drugs, and nucleic acid drugs. Utilize advanced technologies like artificial intelligence and big data to accelerate drug discovery and preclinical research. Establish a comprehensive drug development system, including a non-human primate research center, and strengthen collaborations with international pharmaceutical companies and research institutions to enhance the global competitiveness of the Greater Bay Area.
  • Successful Outcomes: Achievements include vaccines for fish diseases, novel molecular evolution technologies, EB virus candidate vaccines, naringin-based drug formulations, and small molecules for cataract/glaucoma treatment, with commercialization exceeding billions in value.

Foundation and Advantages:
- Four National Key Laboratories in the field of life sciences at Sun Yat-sen University
- Ten Affiliated Hospitals

Strategic Focus:
- Key Areas: Development of novel drugs, advanced medical devices, and integrative medicine combining traditional Chinese and Western practices
- Future Expansion: Elderly care and wellness